Cancer-associated VEGFR2R1032Q sustains receptor activation also by promoting ligand-independent hetero-dimerization with co-expressed wild-type VEGFR2 and translocation into lipid rafts
Cosetta Ravelli(University of Brescia), Stefania Mitola(University of Brescia)
Cited by 3
Related Papers
Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine
|The Journal of Immunology|2006|225
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist
|Oncotarget|2016|50
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis
|Cancer Letters|2020|19
The D647N mutation of FGFR1 induces ligand-independent receptor activation
|Biochimica et Biophysica Acta (BBA) - General Subjects|2023|3